Specials

In vitro synthesis of RNA suitable for RNA therapeutic development and production requires reactions that are not only efficient and scalable but can be adapted to maximize yield and purity for each RNA target. Maximizing reaction performance while minimizing variability, from research and early development through commercial production, is critical to success.The RiboMAX AOF RNA Production System is designed to meet these demands. It features animal-origin-free (AOF), cGMP-manufactured components for robust, scalable in vitro transcription (IVT) of RNA. The system includes a standard IVT protocol along with reaction optimization guidance, which gives you the flexibility to tailor reaction conditions to your RNA target, both maximizing yield and minimizing impurities (such as double-stranded RNA).